ATHA Archived Articles
Athira Pharma (ATHA): Navigating the Challenges of Neurodegenerative Diseases
Published on November 30, 2024
Athira Pharma, Inc. (NASDAQ:ATHA): A Promising Neurodegenerative Disease Specialist Advancing Its Pipeline
Published on September 24, 2024